Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Antidepressant drug fluvoxamine may prevent some serious complications of COVID-19

In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine seems to prevent some of the most serious complications of the illness and make hospitalization and the need for supplemental oxygen less likely.

12 Nov 2020

Baycrest scientists use individualized brain stimulation to treat aphasia in stroke survivors

Baycrest scientists are pioneering the use of individualized brain stimulation therapy to treat aphasia in recovering stroke patients.

12 Nov 2020

KHN’s ‘What the Health?’: Transition interrupted

Five days after the election was called for President-elect Joe Biden, President Donald Trump has not conceded — and instead ordered his administration not to begin the transition of power.

12 Nov 2020

Pollution may bear part of the blame for rapid spread SARS-CoV-2 in the U.S.

The United States may have set itself up for the spread of a pandemic without even knowing it.

12 Nov 2020

Common spike mutation may make SARS-CoV-2 more susceptible to a vaccine

A new study published in Science confirms that SARS-CoV-2 has mutated in a way that's enabled it to spread quickly around the world, but the spike mutation may also make the virus more susceptible to a vaccine.

12 Nov 2020

Time to discuss potentially unpleasant side effects of COVID shots? Scientists say yes.

Drugmaker Pfizer is expected to seek federal permission to release its COVID-19 vaccine by the end of November, a move that holds promise for quelling the pandemic, but also sets up a tight time frame for making sure consumers understand what it will mean to actually get the shots.

12 Nov 2020

Workers who lost jobs due to COVID may need help getting coverage this fall

Michelina Moen lost her job and health insurance in April. Only weeks earlier she had begun to feel ill and not her usual energetic self — in what she describes as a textbook case of "really bad timing."

12 Nov 2020

Nursing homes still see dangerously long waits for COVID test results

Nursing homes are still taking days to get back COVID-19 test results as many shun the Trump administration's central strategy to limit the spread of the virus among old and sick Americans.

12 Nov 2020

Listen: COVID stresses rural hospitals already ‘teetering on the brink’

When KHN Editor-in-Chief Elisabeth Rosenthal heard a sample of the voices that correspondent Sarah Jane Tribble brought back from her reporting trip to rural Kansas, Rosenthal said she knew the story needed to be told through audio.

12 Nov 2020

London-based Veraco launches product range to reduce microbes on frequently touched surfaces

London based Veraco has designed and manufactured a range of Antimicrobial adhesive pads and wraps to be used on frequently touched surfaces, such as door handles, shopping trolleys and handrails.

12 Nov 2020

Beckman Coulter introduces new SARS-CoV-2 IgM assay in countries accepting the CE Mark

Beckman Coulter, a clinical diagnostics leader, today announced the launch of its Access SARS-CoV-2 Immunoglobulin M assay in countries accepting the CE Mark.

From Beckman Coulter Diagnostics 12 Nov 2020

IMCRC launches new funding initiative with an Australian first rapid COVID-19 test

Innovative Manufacturing Cooperative Research Centre (IMCRC) has launched its new funding initiative, IMCRC activate, with an Australian first — the development of a rapid COVID-19 test that uses optical technology.

12 Nov 2020

New £2 million project to improve lives of dementia carers in the UK

Researchers at the University of East Anglia and Norfolk and Suffolk NHS Foundation Trust are launching a new project to improve the lives of dementia carers in the UK.

12 Nov 2020

BMA: Covid-19 vaccine breakthrough brings widespread protection a step closer

BMA encouraged by vaccine ‘breakthrough’ which brings ‘widespread protection a step closer’

12 Nov 2020

National study reveals incidents of avoidable harm in primary care

A national study* of general practices in England has revealed the frequency of incidents of significant avoidable harm in primary care, and also important new details.

12 Nov 2020

New process helps preserve viral vaccines without refrigeration

Ever receive a vaccination that seemed to burn a lot while it was injected? The vaccine solution likely contained a lot of salt or sugar - natural preservatives that help keep it stable, in addition to the cold temperature at which it was kept.

12 Nov 2020

Post-COVID hospitalization has lasting impact on health, work

Surviving a case of COVID-19 that's bad enough to land you in the hospital is hard enough. But life after the hospital stay - and especially after an intensive care stay - is no bed of roses, either, according to a new study.

12 Nov 2020

Routine testing for COVID-19 before major surgery could reduce risk of respiratory complications

Routine testing patients for COVID-19 before major surgery could reduce the risk of respiratory complications and save lives, a new study reveals.

12 Nov 2020

VCU physician receives CHEST Foundation/ATS Research Grant in COVID and Diversity

Peter Jackson, MD, of Virginia Commonwealth University, has been named the first recipient of the CHEST Foundation/ATS Research Grant in COVID and Diversity.

11 Nov 2020

Disinfectants with "virucidal activity against enveloped viruses" effective against SARS-CoV-2

A recent study demonstrated that two commercially available surface disinfectant formulations and one hand disinfection formulation that claim "virucidal activity against enveloped viruses" are effective in inactivating the SARS-CoV-2 virus. Their study has been published on the preprint server bioRxiv.

11 Nov 2020

Pandemic News and Research

Further Reading

Antidepressant drug fluvoxamine may prevent some serious complications of COVID-19

Baycrest scientists use individualized brain stimulation to treat aphasia in stroke survivors

KHN’s ‘What the Health?’: Transition interrupted

Pollution may bear part of the blame for rapid spread SARS-CoV-2 in the U.S.

Common spike mutation may make SARS-CoV-2 more susceptible to a vaccine

Time to discuss potentially unpleasant side effects of COVID shots? Scientists say yes.

Workers who lost jobs due to COVID may need help getting coverage this fall

Nursing homes still see dangerously long waits for COVID test results

Listen: COVID stresses rural hospitals already ‘teetering on the brink’

London-based Veraco launches product range to reduce microbes on frequently touched surfaces

Beckman Coulter introduces new SARS-CoV-2 IgM assay in countries accepting the CE Mark

IMCRC launches new funding initiative with an Australian first rapid COVID-19 test

New £2 million project to improve lives of dementia carers in the UK

BMA: Covid-19 vaccine breakthrough brings widespread protection a step closer

National study reveals incidents of avoidable harm in primary care

New process helps preserve viral vaccines without refrigeration

Post-COVID hospitalization has lasting impact on health, work

Routine testing for COVID-19 before major surgery could reduce risk of respiratory complications

VCU physician receives CHEST Foundation/ATS Research Grant in COVID and Diversity

Disinfectants with "virucidal activity against enveloped viruses" effective against SARS-CoV-2

Best practices - optimize qPCR processes for pathogen detection eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News